文献速递神经外周血管MRCT

颅内动脉瘤壁基线钆增强与长期随访中三维形态学改变的关系

Baseline Gadolinium Enhancement of the Intracranial Aneurysm Wall and 3D Morphologic Change during Long-Term Follow-Up.
PubMed 文献 · AJNR Am J Neuroradiol · 2025-11-03

研究纳入62例患者共72个未破裂颅内动脉瘤,基线行MR动脉瘤壁成像并随访MR或CT血管造影≥1年,用半自动软件定量6项三维形态学参数。基线动脉瘤壁强化(AWE)见于20个动脉瘤(28%),中位随访5.8年;AWE与curvedness(曲度)增加相关(风险差26%,95%CI 9-49%;粗OR 10.7,95%CI 2.2-78.9;校正动脉瘤大小后OR 6.1,95%CI 1.01-50.3),其余5项参数两组间形态学改变比例相当。

要点

  • 基线AWE阳性动脉瘤中curvedness增加者6/20(30%),AWE阴性者2/52(4%)。
  • AWE与curvedness增加相关,校正动脉瘤大小后OR 6.1(95%CI 1.01-50.3)。
  • 其余5项三维形态学参数在AWE阳性与阴性动脉瘤间改变比例相当。

核心结论

  • 长期随访中AWE与动脉瘤形态改变相关,表现为三维定量curvedness增加且不依赖动脉瘤大小,该结果支持AWE与动脉瘤不稳定性相关的既往发现,并提示curvedness可能适合作为捕捉动脉瘤不稳定性的参数。

研究设计与样本

  • 纳入基线行MR动脉瘤壁成像、并随访MR或CT血管造影≥1年的未破裂颅内动脉瘤患者,共62例患者72个动脉瘤;用本院开发软件在基线与随访配对扫描上测量6项三维形态学参数并确定随时间的变化;以改良z分数<-3.5或>3.5判定形态学改变,比较AWE阳性与阴性动脉瘤间形态学改变的比例,计算各参数的风险差及95%CI,对组间改变差异有统计学意义的参数行单变量logistic回归计算OR及95%CI,并在双变量模型中校正动脉瘤大小。

诊断标准与关键数值

  • 形态学改变定义为改良z分数<-3.5或>3.5;基线AWE见于20个动脉瘤(28%),18例患者;中位随访5.8年(四分位距4.6-6.6年);curvedness增加比例AWE阳性动脉瘤6/20(30%)vs AWE阴性动脉瘤2/52(4%),风险差26%(95%CI 9-49%);AWE与curvedness增加的粗OR 10.7(95%CI 2.2-78.9),校正动脉瘤大小后OR 6.1(95%CI 1.01-50.3)。

临床应用与阅片要点

  • 作者认为AWE与动脉瘤不稳定性相关,尤其与curvedness增加相关,并提示curvedness可能是捕捉动脉瘤不稳定性的合适参数;作者指出未来研究需探究该参数增加是否预测动脉瘤破裂。

局限性

  • 原文结论指出未来研究需探究curvedness增加是否预测动脉瘤破裂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Previous studies have shown that intracranial aneurysm wall enhancement (AWE) is associated with aneurysm growth or rupture. These studies assessed growth with manual 2D measurements or eyeballing, both of which are prone to interobserver variability. To minimize this variability, we assessed the association between AWE and semiautomatically quantified 3D morphologic changes in aneurysms during long-term follow-up.

MATERIALS AND METHODS: We included patients with an unruptured intracranial aneurysm who had baseline MR aneurysm wall imaging and were followed with MR or CT angiography for ≥1 year. We used in-house-developed software to measure six 3D morphologic parameters on paired baseline and follow-up scans and determined changes with time. We compared the proportion of aneurysms showing morphologic change (modified z score, <-3.5 or >3.5) between aneurysms with and without AWE. The risk difference was calculated with 95% CI for each morphologic parameter. For parameters with a statistically significant change difference between aneurysms with and without AWE, we calculated ORs with 95% CI in a univariable logistic regression model and adjusted for aneurysm size in a bivariable model.

RESULTS: Sixty-two patients with 72 unruptured intracranial aneurysms met the inclusion criteria. Twenty aneurysms (28%) in 18 patients showed AWE at baseline. The median follow-up was 5.8 years (interquartile range, 4.6-6.6 years). For the parameter curvedness, the proportion of aneurysms showing an increase was higher in aneurysms with AWE (6 of 20, 30%) than in aneurysms without AWE (2 of 52, 4%), with a risk difference of 26%; 95% CI, 9-49%. For the other 5 morphologic parameters, the proportion of aneurysms with morphologic change was comparable between aneurysms with and without AWE. In logistic regression analysis, AWE was associated with a curvedness increase (crude OR, 10.7; 95% CI, 2.2-78.9, adjusted OR, 6.1; 95% CI, 1.01-50.3).

CONCLUSIONS: AWE was associated with aneurysm shape change during long-term follow-up, with an increase in 3D quantified curvedness that was independent of aneurysm size. This result reinforces previous findings that AWE is associated with aneurysm instability, in particular curvedness increase, and suggests that curvedness could be a suitable parameter to capture aneurysm instability. Future studies need to investigate whether an increase in this parameter predicts aneurysmal rupture.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Kamphuis MJ, van der Kamp LT, van Vliet JT, et al. Baseline Gadolinium Enhancement of the Intracranial Aneurysm Wall and 3D Morphologic Change during Long-Term Follow-Up. AJNR Am J Neuroradiol. 2025. PMID: 40335282. doi:10.3174/ajnr.A8825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。